We proposed to specify in new 425.600(h)(2), for agreement periods beginning on or after January 1, 2027, if an ACO is determined to be experienced with performance-based risk Medicare ACO initiatives, the ACO may enter either the BASIC track Level E for all performance years of the agreement period, or the ENHANCED track, subject to the proposed exception prohibiting ACOs with fewer than 5,000 assigned beneficiaries in BY1, BY2, or both, from participating in the ENHANCED track specified in new 425.600(h)(3) (described in section III.F.4.b.(2).(b) of the CY 2026 PFS proposed rule)
Syra Hanif helps patients understand these factors and choose a plan that makes sense for their goals and budget
This product is supplied as a 99.9% pure lyophilized (freeze-dried) powder in vial strengths from 2 mg to 20 mg, designed for precise measuring and stable storage before reconstitution
In the REDEFINE 2 trial involving participants with type 2 diabetes, CagriSema significantly reduced HbA1c beyond what semaglutide alone achieved
The product comes from controlled sterile manufacturing with clear documentation
However, in some people, the body produces too much uric acid or excretes too little, leading to a buildup of uric acid in the bloodstream